Brent L. Kane

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes

Donald B. Fuller, Aaron D. Falchook, Tami Crabtree et al. · European Urology Oncology · 2018 · 62 citations · Full text

Octreotide Acetate in Prevention of Chemoradiation-Induced Diarrhea in Anorectal Cancer: Randomized RTOG Trial 0315

Babu Zachariah, Clement K. Gwede, J. James et al. · JNCI Journal of the National Cancer Institute · 2010 · 38 citations

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial

Kyle Wang, Ronald C. Chen, Brent L. Kane et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 25 citations

Urology, Bowel Quality, Medicine +6

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Donald B. Fuller, Tami Crabtree, Brent L. Kane et al. · Frontiers in Oncology · 2022 · 13 citations · Full text